Use of Next-Generation Sequencing to Support the Diagnosis of Familial Interstitial Pneumonia

Familial interstitial pneumonia (FIP) is defined as idiopathic interstitial lung disease (ILD) in two or more relatives. Genetic studies on familial ILD discovered variants in several genes or associations with genetic polymorphisms. The aim of this study was to describe the clinical features of patients with suspected FIP and to analyze the genetic variants detected through next-generation sequencing (NGS) genetic testing. A retrospective analysis was conducted in patients followed in an ILD outpatient clinic who had ILD and a family history of ILD in at least one first- or second-degree relative and who underwent NGS between 2017 and 2021. Only patients with at least one genetic variant were included. Genetic testing was performed on 20 patients; of these, 13 patients had a variant in at least one gene with a known association with familial ILD. Variants in genes implicated in telomere and surfactant homeostasis and MUC5B variants were detected. Most variants were classified with uncertain clinical significance. Probable usual interstitial pneumonia radiological and histological patterns were the most frequently identified. The most prevalent phenotype was idiopathic pulmonary fibrosis. Pulmonologists should be aware of familial forms of ILD and genetic diagnosis.

[1]  Jonathan H. Chung,et al.  Diagnostic test interpretation and referral delay in patients with interstitial lung disease , 2019, Respiratory research.

[2]  P. Dieudé,et al.  The genetics of interstitial lung diseases , 2019, European Respiratory Review.

[3]  W. Seeger,et al.  Clinical characteristics of patients with familial idiopathic pulmonary fibrosis (f-IPF) , 2019, BMC Pulmonary Medicine.

[4]  A. Fabro,et al.  Familial pulmonary fibrosis: a heterogeneous spectrum of presentations , 2019, Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia.

[5]  I. Noth,et al.  Integrating Genomics Into Management of Fibrotic Interstitial Lung Disease , 2019, Chest.

[6]  M. Broder,et al.  Potential Delays in Diagnosis of Idiopathic Pulmonary Fibrosis in Medicare Beneficiaries , 2019, Annals of the American Thoracic Society.

[7]  R. Borie,et al.  Clinical implications of telomere dysfunction in lung fibrosis , 2018, Current opinion in pulmonary medicine.

[8]  David J. Lederer,et al.  Barriers to timely diagnosis of interstitial lung disease in the real world: the INTENSITY survey , 2018, BMC Pulmonary Medicine.

[9]  B. Thyagarajan,et al.  Review of Clinical Next-Generation Sequencing. , 2017, Archives of pathology & laboratory medicine.

[10]  D. Schwartz,et al.  Genetic Evaluation and Testing of Patients and Families with Idiopathic Pulmonary Fibrosis. , 2017, American journal of respiratory and critical care medicine.

[11]  L. Gouya,et al.  Management of suspected monogenic lung fibrosis in a specialised centre , 2017, European Respiratory Review.

[12]  C. Garcia,et al.  Telomere length in patients with pulmonary fibrosis associated with chronic lung allograft dysfunction and post-lung transplantation survival. , 2017, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[13]  P. Revy,et al.  Prevalence and characteristics of TERT and TERC mutations in suspected genetic pulmonary fibrosis , 2016, European Respiratory Journal.

[14]  K. Batra,et al.  Telomere-related lung fibrosis is diagnostically heterogeneous but uniformly progressive , 2016, European Respiratory Journal.

[15]  P. Revy,et al.  Heterozygous RTEL1 mutations are associated with familial pulmonary fibrosis , 2015, European Respiratory Journal.

[16]  S. E. Stanley,et al.  Exome sequencing identifies mutant TINF2 in a family with pulmonary fibrosis. , 2015, Chest.

[17]  R. Borie,et al.  Familial pulmonary fibrosis. , 2015, Revue des maladies respiratoires.

[18]  S. Mane,et al.  Exome Sequencing Links Mutations in PARN and RTEL1 with Familial Pulmonary Fibrosis and Telomere Shortening , 2015, Nature Genetics.

[19]  Zhongming Zhao,et al.  Rare variants in RTEL1 are associated with familial interstitial pneumonia. , 2015, American journal of respiratory and critical care medicine.

[20]  Bale,et al.  Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.

[21]  J. W. Lee,et al.  Extensive phenotyping of individuals at risk for familial interstitial pneumonia reveals clues to the pathogenesis of interstitial lung disease. , 2015, American journal of respiratory and critical care medicine.

[22]  E. Blackburn,et al.  The telomere syndromes , 2012, Nature Reviews Genetics.

[23]  R. Borie,et al.  Familial forms of nonspecific interstitial pneumonia/idiopathic pulmonary fibrosis: clinical course and genetic background , 2012, Current opinion in pulmonary medicine.

[24]  C. Garcia,et al.  Genetic interstitial lung disease. , 2012, Clinics in chest medicine.

[25]  G. Raghu,et al.  Telomere Lengths, Pulmonary Fibrosis and Telomerase (TERT) Mutations , 2010, PloS one.

[26]  Margaret A. Strong,et al.  Short Telomeres, even in the Presence of Telomerase, Limit Tissue Renewal Capacity , 2005, Cell.

[27]  H Page McAdams,et al.  Clinical and pathologic features of familial interstitial pneumonia. , 2005, American journal of respiratory and critical care medicine.

[28]  T. Hartman,et al.  Familial idiopathic pulmonary fibrosis: clinical features and outcome. , 2005, Chest.

[29]  T. Laitinen,et al.  Nationwide prevalence of sporadic and familial idiopathic pulmonary fibrosis: evidence of founder effect among multiplex families in Finland , 2002, Thorax.